Much of the benefit Biotechnology provides to society comes from its ability to provide useful, new, valuable proteins. FhCMB has selected an interlocking set of platform technologies that work together to provide rapid, low-cost and safe production of valuable proteins. These are combined with directed evolution to improve function. We offer comprehensive, plant-based expression services, including: molecular farming, directed evolution, functional genomics, and vaccine development.

Business Areas
Our core platform technologies are employed in the following business areas to help partners effectively and efficiently meet their protein production needs:

Vaccines
Transient gene expression provide a particularly effective modality for developing vaccines used in the prevention and treatment of diseases, including applications for anti-bioterrorism. To view our process, click here for an animated sequence (Real Player required).

Protein Therapeutics
Molecular farming offers a safer and less expensive means of producing monoclonal antibodies (Mabs) while eliminating the risk of contamination by animal pathogens, with low investment scale-up.

Industrial Enzymes
Molecular farming stimulates higher yield and significantly reduces the costs associated with industrial biocatalysis; while directed evolution allows improvement of enzyme function.

Ag Biotech
Transient gene expression helps define the function of new genes and can be used to alter the metabolism of plants for the production of desired metabolites.